Abivax (ABVX) Total Non-Current Liabilities (2021 - 2026)
Abivax (ABVX) reported Total Non-Current Liabilities of $27.7 million for Q2 2026, down 57.5% from $65.17 million a year earlier and down 56.3% from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Abivax posted Total Non-Current Liabilities of $77.67 million, up 5.6% from FY2024.
- Total Non-Current Liabilities has increased for three consecutive years, with a four-year compound annual growth rate of 7.7% (FY2021 to FY2025).
- By year, Total Non-Current Liabilities came in at $73.51 million in FY2024 (+64.6%), $44.67 million in FY2023 (+148.1%), $18.01 million in FY2022 (-68.8%) and $57.79 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q4 2022.
- Year over year, Total Non-Current Liabilities gained in two of the last five quarters, with an average decline of 4.6%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $63.39 million (Q1 2026), $77.67 million (Q4 2025) and $72.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Abivax | 7.07 Bn | 4.69 Bn | - | 27.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.70 Mn |
| Mar 31, 2026 | 63.39 Mn |
| Dec 31, 2025 | 77.67 Mn |
| Sep 30, 2025 | 72.80 Mn |
| Jun 30, 2025 | 65.17 Mn |
| Mar 31, 2025 | 73.38 Mn |
| Dec 31, 2024 | 73.51 Mn |
| Jun 30, 2024 | 83.58 Mn |
| Dec 31, 2023 | 44.67 Mn |
| Dec 31, 2022 | 18.01 Mn |
| Dec 31, 2021 | 57.79 Mn |
API Access
Abivax Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();